Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety assessment of trabectedin in translocation-related sarcomas
jRCT2080222464Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Apr 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trabectedin in translocation-related sarcoma (TRS), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
trabectedin
03
Conditions
translocation-related sarcoma (TRS)
Beyond the preview
Go deeper on jRCT2080222464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222464.